| EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines JA Witjes, E Compérat, NC Cowan, M De Santis, G Gakis, T Lebret, ... European urology 65 (4), 778-792, 2014 | 1214 | 2014 |
| Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines A Stenzl, NC Cowan, M De Santis, MA Kuczyk, AS Merseburger, MJ Ribal, ... European urology 59 (6), 1009-1018, 2011 | 768 | 2011 |
| Extended radical lymphadenectomy in patients with urothelial bladder cancer:: results of a prospective multicenter study J Leissner, MA Ghoneim, H Abol-Enein, JW Thüroff, L Franzaring, M Fisch, ... The Journal of urology 171 (1), 139-144, 2004 | 603 | 2004 |
| The updated EAU guidelines on muscle-invasive and metastatic bladder cancer A Stenzl, NC Cowan, M De Santis, G Jakse, MA Kuczyk, AS Merseburger, ... European urology 55 (4), 815-825, 2009 | 484 | 2009 |
| Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies A Sherif, L Holmberg, E Rintala, O Mestad, J Nilsson, S Nilsson, ... European urology 45 (3), 297-303, 2004 | 305 | 2004 |
| Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial … R Rosenblatt, A Sherif, E Rintala, R Wahlqvist, A Ullén, S Nilsson, ... European urology 61 (6), 1229-1238, 2012 | 288 | 2012 |
| Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer CN Sternberg, SM Donat, J Bellmunt, RE Millikan, W Stadler, P De Mulder, ... Urology 69 (1), 62-79, 2007 | 242 | 2007 |
| Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer-Nordic cystectomy trial 2 A Sherif, E Rintala, O Mestad, J Nilsson, L Holmberg, S Nilsson, ... Scandinavian journal of urology and nephrology 36 (6), 419-425, 2002 | 239 | 2002 |
| The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review HM Bruins, E Veskimae, V Hernandez, M Imamura, MM Neuberger, ... European urology 66 (6), 1065-1077, 2014 | 228 | 2014 |
| FOXP3 and survival in urinary bladder cancer ME Winerdal, P Marits, M Winerdal, M Hasan, R Rosenblatt, A Tolf, ... BJU international 108 (10), 1672-1678, 2011 | 195 | 2011 |
| EAU-ESMO Consensus statements on the management of advanced and variant bladder cancer—an international collaborative multistakeholder effort†: under the auspices of the EAU … JA Witjes, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ... European urology 77 (2), 223-250, 2020 | 194 | 2020 |
| Arterio-ureteral fistula–a systematic review D Bergqvist, H Pärsson, A Sherif European Journal of Vascular and Endovascular Surgery 22 (3), 191-196, 2001 | 189 | 2001 |
| EAU guidelines on primary urethral carcinoma G Gakis, JA Witjes, E Comperat, NC Cowan, M De Santis, T Lebret, ... European Urology 64 (5), 823-830, 2013 | 184 | 2013 |
| Lymphatic mapping and detection of sentinel nodes in patients with bladder cancer A Sherif, M De La Torre, PU Malmström, M Thörn The Journal of urology 166 (3), 812-815, 2001 | 154 | 2001 |
| Bladder Cancer Muscle-invasive and metastatic A Stenzl, J Witjes, E Compérat, NC Cowan, M De Santis, M Kuczyk, ... UPDATE, 2012 | 115 | 2012 |
| Hybrid SPECT-CT: an additional technique for sentinel node detection of patients with invasive bladder cancer A Sherif, U Garske, M de La Torre, M Thörn european urology 50 (1), 83-91, 2006 | 104 | 2006 |
| EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU … A Horwich, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ... Annals of Oncology 30 (11), 1697-1727, 2019 | 90 | 2019 |
| Muscle-invasive and metastatic bladder cancer JA Witjes, M Bruins, R Cathomas, E Compérat, NC Cowan, G Gakis, ... European Association of Urology Guidelines, 7-10, 2018 | 84 | 2018 |
| Swedish National Penile Cancer Register: incidence, tumour characteristics, management and survival P Kirrander, A Sherif, B Friedrich, M Lambe, U Håkansson, ... BJU international 117 (2), 287-292, 2016 | 77 | 2016 |
| Adjuvant chemotherapy for invasive bladder cancer (individual patient data) CL Vale, Advanced Bladder Cancer Meta‐analysis Collaboration, ... Cochrane Database of Systematic Reviews 2011 (4), 1996 | 72 | 1996 |
Ola winqvistProfessor i immunologi, Karolinska Institutet在 ki.se 的电子邮件经过验证
